Pfizer (PFE) Exchange Rate Effect (2009 - 2026)
Pfizer (PFE) posted quarterly Exchange Rate Effect of $19.0 million for Q1 2026, up 371.43% year-over-year from $4.0 million in Q1 2025, and up 280.0% quarter-over-quarter from $5.0 million in Q4 2025.
Pfizer (PFE) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Exchange Rate Effect for 18 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 371.43% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $67.0 million (up 174.44% YoY), while the FY2025 annual figure was $41.0 million, up 162.12% from the prior year.
- Exchange Rate Effect improved to $19.0 million in Q1 2026 per PFE's latest filing, from $5.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $41.0 million in Q2 2025 and bottomed at -$66.0 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$7.5 million across 5 years, with a median of -$2.0 million in 2023.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 1420.0% — and 2026, when it jumped 371.43%.
- Pfizer's Exchange Rate Effect stood at -$66.0 million in 2022, then jumped by 98.48% to -$1.0 million in 2023, then slumped by 3600.0% to -$37.0 million in 2024, then jumped by 113.51% to $5.0 million in 2025, then surged by 280.0% to $19.0 million in 2026.
- Business Quant data shows PFE's Exchange Rate Effect at $19.0 million in Q1 2026, $5.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -4.00 Mn |
| Jun 28, 2026 | -4.00 Mn |
| Mar 29, 2026 | 19.00 Mn |
| Mar 29, 2026 | 19.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 28, 2025 | 2.00 Mn |
| Sep 28, 2025 | 2.00 Mn |
| Jun 29, 2025 | 41.00 Mn |
| Jun 29, 2025 | 41.00 Mn |
| Mar 30, 2025 | -7.00 Mn |
| Mar 30, 2025 | -7.00 Mn |
| Sep 29, 2024 | -37.00 Mn |
| Sep 29, 2024 | -37.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | -28.00 Mn |
| Mar 31, 2024 | -28.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |